Novavax ends COVID vaccine sale agreement with Gavi

Novavax Inc said on Monday it has delivered a written notice to Gavi, the Vaccine Alliance, terminating an agreement for sale of its COVID-19 vaccine to low- and middle-income countries.

The company cited Gavi's failure to procure the 350 million doses it had agreed to buy in May last year.